The influence of recombinant human insulin-like growth factor-I (rhIGF-I) on cell growth and cytotoxicity of drugs in childhood rhabdomyosarcoma cell lines and xenograft models

2000 ◽  
Vol 45 (1) ◽  
pp. 21-30 ◽  
Author(s):  
Corrie E.M. Gidding ◽  
Glen S. Germain ◽  
Michael B. Dilling ◽  
Tiny G. J. Meeuwsen-de Boer ◽  
Richard A. Ashmun ◽  
...  
Keyword(s):  
Growth Factor ◽  
Cell Growth ◽  
Cell Lines ◽  
Human Insulin ◽  
Insulin Like Growth Factor ◽  
Recombinant Human Insulin ◽  
Factor I ◽  
Rhabdomyosarcoma Cell ◽  
Xenograft Models ◽  
Childhood Rhabdomyosarcoma

Cost Effectiveness of Recombinant Human Insulin-Like Growth Factor I Therapy in Patients with ALS

1999 ◽  
Vol 15 (2) ◽  
pp. 179-195 ◽  
Author(s):  
Stacey J. Ackerman ◽  
Erin M. Sullivan ◽  
Kathleen M. Beusterien ◽  
Howard M. Natter ◽  
Deborah F. Gelinas ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Growth Factor ◽  
Human Insulin ◽  
Insulin Like Growth Factor ◽  
Recombinant Human Insulin ◽  
Factor I ◽  
Growth Factor I

scholarly journals Novel markers to detect recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes

2016 ◽  
Vol 9 (1) ◽  
pp. 30-37 ◽  
Author(s):  
Richard I. G. Holt ◽  
Nishan Guha ◽  
Walailuck Böhning ◽  
Christiaan Bartlett ◽  
David A. Cowan ◽  
...  
Keyword(s):  
Growth Factor ◽  
Human Insulin ◽  
Binding Protein ◽  
Insulin Like Growth Factor ◽  
Recombinant Human Insulin ◽  
Factor I ◽  
Growth Factor I
Sign in / Sign up

Export Citation Format

Share Document